HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mukesh Kumar Selected Research

SARS-CoV-2 papain-like protease

1/2022Evaluating Stability and Activity of SARS-CoV-2 PLpro for High-throughput Screening of Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mukesh Kumar Research Topics

Disease

39Neoplasms (Cancer)
03/2024 - 07/2002
34Infections
12/2023 - 11/2006
15Inflammation (Inflammations)
12/2023 - 09/2002
13COVID-19
02/2024 - 01/2020
12Pain (Aches)
02/2024 - 10/2005
10West Nile Fever
01/2019 - 03/2009
7Breast Neoplasms (Breast Cancer)
08/2023 - 07/2017
6Stroke (Strokes)
04/2024 - 06/2020
6Body Weight (Weight, Body)
08/2023 - 01/2017
6Zika Virus Infection
07/2023 - 01/2016
5Ischemic Stroke
02/2024 - 06/2020
5Hypoxia (Hypoxemia)
11/2023 - 09/2016
5Myocardial Infarction
11/2022 - 08/2016
5Encephalitis (Encephalitis, Rasmussen)
01/2021 - 04/2013
5Asthma (Bronchial Asthma)
09/2008 - 07/2002
4Hypersensitivity (Allergy)
02/2024 - 02/2020
4Pneumonia (Pneumonitis)
11/2023 - 08/2002
4Hepatocellular Carcinoma (Hepatoma)
08/2023 - 03/2010
4Virus Diseases (Viral Diseases)
01/2023 - 04/2013
4Keratoconus
05/2022 - 05/2016
4Edema (Dropsy)
07/2021 - 01/2019
4Acquired Immunodeficiency Syndrome (AIDS)
05/2020 - 07/2005
3Glioblastoma (Glioblastoma Multiforme)
03/2024 - 09/2016
3Acute Kidney Injury (Acute Renal Failure)
03/2024 - 01/2018
3Wounds and Injuries (Trauma)
02/2024 - 09/2002
3Septic Shock (Toxic Shock Syndrome)
02/2024 - 09/2017
3Hyperthyroidism
01/2024 - 01/2021
3Sepsis (Septicemia)
05/2023 - 09/2017
3Disease Progression
01/2023 - 02/2010
3Carcinogenesis
01/2023 - 05/2013
3Neuroblastoma
01/2023 - 10/2010
3Thrombosis (Thrombus)
11/2022 - 05/2011
3Tuberculosis (Tuberculoses)
10/2022 - 10/2011
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2014
3Postoperative Pain
09/2021 - 10/2005
3Lymphoma (Lymphomas)
01/2021 - 02/2015
3Aneuploidy (Aneuploid)
01/2020 - 05/2015
3Respiratory Syncytial Virus Infections
02/2005 - 07/2002
2Alcoholism (Alcohol Abuse)
03/2024 - 11/2020
2Liver Diseases (Liver Disease)
03/2024 - 07/2023
2Hypotension (Low Blood Pressure)
02/2024 - 04/2022

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2002
13CytokinesIBA
03/2024 - 09/2002
10Antiviral Agents (Antivirals)IBA
02/2024 - 07/2002
8AntibodiesIBA
01/2024 - 01/2012
7Messenger RNA (mRNA)IBA
03/2024 - 08/2002
7DNA (Deoxyribonucleic Acid)IBA
08/2022 - 08/2002
7Immunoglobulin M (IgM)IBA
04/2018 - 01/2012
7Immunoglobulin G (IgG)IBA
04/2018 - 07/2006
6VaccinesIBA
12/2022 - 02/2010
6Analgesics (Analgesic Drugs)IBA
09/2022 - 12/2007
5Immunoglobulin E (IgE)IBA
02/2024 - 09/2002
5LipidsIBA
12/2023 - 01/2018
5Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 04/2016
5MicroRNAs (MicroRNA)IBA
08/2023 - 11/2013
5ChemokinesIBA
12/2021 - 04/2013
5Telomerase (Telomerase Reverse Transcriptase)IBA
10/2017 - 07/2011
4Peptides (Polypeptides)IBA
03/2024 - 07/2017
4Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2015
4AntigensIBA
01/2024 - 08/2002
4Neutralizing AntibodiesIBA
01/2024 - 06/2014
4ArsenicIBA
08/2023 - 01/2021
4RNA (Ribonucleic Acid)IBA
07/2023 - 03/2011
4AntioxidantsIBA
01/2023 - 01/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 03/2014
4EnzymesIBA
01/2022 - 03/2011
3Oxygen (Dioxygen)IBA
11/2023 - 03/2017
3Ropivacaine (Naropin)FDA LinkGeneric
08/2023 - 10/2017
3Small Interfering RNA (siRNA)IBA
06/2023 - 03/2010
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2023 - 02/2020
3Monoclonal AntibodiesIBA
12/2022 - 07/2017
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 02/2009
3Phosphotransferases (Kinase)IBA
01/2022 - 02/2009
3CreatinineIBA
01/2022 - 03/2017
3Human immunodeficiency virus 1 p16 proteaseIBA
05/2020 - 06/2002
3ribosomal protein S30IBA
01/2020 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
04/2018 - 09/2016
3CopperIBA
11/2017 - 03/2010
3Coloring Agents (Dyes)IBA
07/2016 - 01/2016
3OvalbuminIBA
09/2008 - 09/2002
3Interferon-gamma (Interferon, gamma)IBA
09/2008 - 07/2002
3ChitosanIBA
09/2008 - 08/2002
3AllergensIBA
10/2003 - 09/2002
2LigandsIBA
03/2024 - 03/2019
2Aurora KinasesIBA
03/2024 - 03/2021
2UbiquitinIBA
02/2024 - 10/2021
2Phospholipids (Phosphatides)FDA LinkGeneric
02/2024 - 01/2020

Therapy/Procedure

42Therapeutics
03/2024 - 10/2003
5Drug Therapy (Chemotherapy)
01/2024 - 11/2016
4Immunotherapy
01/2024 - 01/2017
4Contact Lenses
05/2022 - 05/2016
4Artificial Respiration (Mechanical Ventilation)
08/2020 - 09/2017
3Thrombectomy
02/2024 - 01/2023
3Length of Stay
01/2024 - 02/2015
3Liver Transplantation
08/2023 - 06/2022
3Percutaneous Coronary Intervention
11/2022 - 11/2019
3Penetrating Keratoplasty
05/2022 - 12/2019
3General Anesthesia
01/2022 - 04/2011
2Critical Care (Surgical Intensive Care)
03/2024 - 01/2021
2Secondary Prevention
02/2024 - 06/2020